Once-monthly radiotherapy for the palliation of pelvic gynecological malignancy.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 6193037)

Published in Gynecol Oncol on August 01, 1983

Authors

D I Hodson, G V Krepart

Articles by these authors

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91

Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01

Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. J Clin Oncol (1998) 1.97

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck (2001) 1.61

Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix. Am J Obstet Gynecol (1984) 1.32

Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.23

Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecol Oncol (1991) 1.11

Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) (2006) 1.05

Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol (2001) 0.96

The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol (1993) 0.94

The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol (2002) 0.90

Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin. Cancer Treat Rep (1987) 0.89

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol (1994) 0.88

Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma. Gynecol Oncol (1988) 0.88

Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience. Gynecol Oncol (1997) 0.88

Glassy cell carcinoma of the cervix: a bimodal treatment strategy. Gynecol Oncol (1992) 0.85

Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol (1994) 0.85

Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck (1994) 0.85

Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol (1986) 0.84

Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol (1994) 0.84

Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. Int J Radiat Oncol Biol Phys (2003) 0.81

Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions. Am J Pathol (1983) 0.81

The role of computed tomography in the T classification of laryngeal carcinoma. Cancer (2001) 0.81

Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY. Int J Radiat Oncol Biol Phys (1994) 0.81

Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol (1997) 0.80

Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol (1986) 0.80

Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada. Clin Oncol (R Coll Radiol) (2010) 0.79

Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly? Gynecol Oncol (1999) 0.79

Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol (1988) 0.78

Nitric oxide and anti-cancer therapy. Cancer Treat Rev (1995) 0.78

Management of oral mucosal dysplasia with beta-carotene retinoic acid: a pilot cross-over study. Cancer Detect Prev (1991) 0.78

Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate. Obstet Gynecol (1991) 0.77

Quantitative computed tomography of the brain with xenon enhancement: a phantom study with the GE9800 scanner. Phys Med Biol (1990) 0.77

Physical aspects of external beam radiotherapy for the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys (1990) 0.77

0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers. Br J Radiol (2015) 0.76

Ovarian carcinoma of low malignant potential: staging and treatment. Am J Obstet Gynecol (1986) 0.76

Early ovarian cancer: value of a negative staging laparotomy. Eur J Gynaecol Oncol (1996) 0.76

Progress in screening for cervical cancer. CMAJ (1996) 0.75

Long-term results of a pilot study for the treatment of advanced unresectable head and neck tumors by combination chemotherapy and split course radiotherapy. J Otolaryngol (1986) 0.75

Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada. Clin Oncol (R Coll Radiol) (2003) 0.75

Hypothyroidism complicating combined modality therapy for head and neck malignancy. Int J Radiat Oncol Biol Phys (1981) 0.75

A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic test. Gynecol Oncol (1987) 0.75

Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells. Anticancer Res (2000) 0.75

Factor analysis of false-negative second-look laparotomy. Gynecol Oncol (1990) 0.75

Hypofractionated radiotherapy for the palliation of advanced pelvic malignancy. Int J Radiat Oncol Biol Phys (1983) 0.75

Peritoneovenous shunt for palliation of gynecologic malignant ascites. J Am Coll Surg (1995) 0.75

Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys (1984) 0.75